- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. ...
- Purchase now or later. ...
- Check in on your investment.
Is VXRT a good stock to buy?
Is VAXART Stock a good buy in 2022, according to Wall Street analysts? The consensus among 4 Wall Street analysts covering (NASDAQ: VXRT) stock is to Strong Buy VXRT stock.
Is vaxart a public company?
Our common stock is listed on the Nasdaq Capital Market under the symbol "VXRT." On April 8, 2019, the last reported sale price of our common stock was $1.49 per share. There is no established public trading market for the pre-funded warrants and the common warrants, and we do not expect a market to develop.
Who is VXRT?
Description. Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform.
Will VXRT stock go back up?
Vaxart: 25,752% implied sales growth by 2025 Drug-developer Vaxart (VXRT -6.18%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.
Why did vaxart stock go up today?
Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart's stock price was up more than 12%.
How long has vaxart been around?
VaxartVaxart's HQ located in South San FranciscoFounded2004FounderSean TuckerHeadquartersSouth San Francisco, CaliforniaKey peopleAndrei "Andy" Floroiu (CEO)10 more rows
How do I contact vaxart?
Contact Email [email protected] Number 8667032712.
How many employees does vaxart have?
110Vaxart / Number of employees (2021)